249 related articles for article (PubMed ID: 24054056)
1. Receptors involved in cell activation by antiphospholipid antibodies.
Brandt KJ; Kruithof EK; de Moerloose P
Thromb Res; 2013 Oct; 132(4):408-13. PubMed ID: 24054056
[TBL] [Abstract][Full Text] [Related]
2. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.
Xie H; Sheng L; Zhou H; Yan J
Br J Haematol; 2014 Jan; 164(2):165-76. PubMed ID: 24180619
[TBL] [Abstract][Full Text] [Related]
3. NF-κB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes.
Brandt KJ; Fickentscher C; Boehlen F; Kruithof EK; de Moerloose P
J Thromb Haemost; 2014 May; 12(5):779-91. PubMed ID: 24612386
[TBL] [Abstract][Full Text] [Related]
4. From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome.
Du VX; Kelchtermans H; de Groot PG; de Laat B
Thromb Res; 2013 Sep; 132(3):319-26. PubMed ID: 23958468
[TBL] [Abstract][Full Text] [Related]
5. [Antiphospholipid syndrome and pregnancy].
Koleva R; Chernev T; Karag'ozova Zh; Dimitrova V
Akush Ginekol (Sofiia); 2004; 43(1):36-42. PubMed ID: 15168653
[TBL] [Abstract][Full Text] [Related]
6. The class I phosphoinositide 3-kinases α and β control antiphospholipid antibodies-induced platelet activation.
Terrisse AD; Laurent PA; Garcia C; Gratacap MP; Vanhaesebroeck B; Sié P; Payrastre B
Thromb Haemost; 2016 Jun; 115(6):1138-46. PubMed ID: 26818901
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
Bidot CJ; Jy W; Horstman LL; Ahn ER; Yaniz M; Ahn YS
Am J Hematol; 2006 Jun; 81(6):391-6. PubMed ID: 16680753
[TBL] [Abstract][Full Text] [Related]
8. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome.
Pierangeli SS; Vega-Ostertag ME; González EB
Expert Rev Mol Med; 2007 Nov; 9(30):1-15. PubMed ID: 17997880
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4.
Laplante P; Fuentes R; Salem D; Subang R; Gillis MA; Hachem A; Farhat N; Qureshi ST; Fletcher CA; Roubey RA; Merhi Y; Thorin É; Levine JS; Mackman N; Rauch J
Lupus; 2016 Feb; 25(2):162-76. PubMed ID: 26391610
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of anti-phospholipid antibody formation and action.
de Groot PG
Thromb Res; 2011 Feb; 127 Suppl 3():S40-2. PubMed ID: 21262437
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
de Laat B; Mertens K; de Groot PG
Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
[TBL] [Abstract][Full Text] [Related]
12. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications.
Willemze R; Bradford RL; Mooberry MJ; Roubey RA; Key NS
Thromb Res; 2014 Feb; 133(2):187-9. PubMed ID: 24332063
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies in arterial thrombosis.
Koike T
Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
[TBL] [Abstract][Full Text] [Related]
14. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
[TBL] [Abstract][Full Text] [Related]
15. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.
Breen KA; Seed P; Parmar K; Moore GW; Stuart-Smith SE; Hunt BJ
Thromb Haemost; 2012 Mar; 107(3):423-9. PubMed ID: 22234447
[TBL] [Abstract][Full Text] [Related]
16. Complement and thrombosis in the antiphospholipid syndrome.
Oku K; Nakamura H; Kono M; Ohmura K; Kato M; Bohgaki T; Horita T; Yasuda S; Amengual O; Atsumi T
Autoimmun Rev; 2016 Oct; 15(10):1001-4. PubMed ID: 27485012
[TBL] [Abstract][Full Text] [Related]
17. The antiphospholipid syndrome.
Wautrecht JC
Acta Neurol Belg; 2002 Dec; 102(4):158-62. PubMed ID: 12534241
[TBL] [Abstract][Full Text] [Related]
18. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
[TBL] [Abstract][Full Text] [Related]
19. Annexin A2 autoantibodies in thrombosis and autoimmune diseases.
Cañas F; Simonin L; Couturaud F; Renaudineau Y
Thromb Res; 2015 Feb; 135(2):226-30. PubMed ID: 25533130
[TBL] [Abstract][Full Text] [Related]
20. [Antiphospholipid antibodies and cancer].
Scrobohaci ML
Pathol Biol (Paris); 2008 Jun; 56(4):245-50. PubMed ID: 18456436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
